Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series

OBJECTIVE: To describe clinical and imaging responses in neurosarcoidosis to infliximab, a monoclonal antibody against tumor necrosis factor–α. METHODS: Investigators at 6 US centers retrospectively identified patients with CNS sarcoidosis treated with infliximab, including only patients with defini...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurology
Hlavní autoři: Gelfand, Jeffrey M., Bradshaw, Michael J., Stern, Barney J., Clifford, David B., Wang, Yunxia, Cho, Tracey A., Koth, Laura L., Hauser, Stephen L., Dierkhising, Jason, Vu, NgocHanh, Sriram, Subramaniam, Moses, Harold, Bagnato, Francesca, Kaufmann, Jeffrey A., Ammah, Deidre J., Yohannes, Tsion H., Hamblin, Mark J., Venna, Nagagopal, Green, Ari J., Pawate, Siddharama
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5711506/
https://ncbi.nlm.nih.gov/pubmed/29030454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000004644
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky